SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndine Biomed Regulatory News (OBI)

Share Price Information for Ondine Biomed (OBI)

Share Price is delayed by 15 minutes
Get Live Data
13.00    0.25 (1.96%)
Bid:
12.50
Ask:
13.50
Spread: 1.00 (8.00%)
Market Cap: £67.54m
OBI Live PriceLast checked at - London Stock Exchange

Intraday Ondine Biomed Share Chart

Date   Source Headline
27th Sep 20227:00 amRNSInterim results for the six months to 30 June 2022
23rd Sep 20229:00 amRNSThe Ottawa Hospital pilots nasal disinfection
20th Sep 20229:34 amRNSNew research presented on photodisinfection
7th Sep 202212:30 pmRNSOndine’s photodisinfection kills ESKAPE pathogens
6th Sep 20227:00 amRNSOndine reports successful US Phase 2 trial data
31st Aug 202210:49 amRNSNature reports Ondine therapy suppresses COVID-19
16th Aug 20227:00 amRNSOndine appoints RBC and Singer as joint brokers
8th Aug 202210:02 amRNSOndine completes US Phase II trial recruitment
26th Jul 20227:00 amRNSCompletion of Nominated Adviser due diligence
22nd Jul 20227:00 amRNSIssue of Equity
19th Jul 20227:00 amRNSOndine completes successful SARS-CoV-2 trial
8th Jun 20227:00 amRNSResult of AGM
7th Jun 20227:00 amRNSPosting of annual report
19th May 20227:00 amRNSFull Year Results to 31 December 2021
17th May 20227:00 amRNSNotice of AGM
10th May 202210:30 amRNSWHO calls for better infection prevention
27th Apr 20224:30 pmRNSAppointment of Nominated Adviser
5th Apr 20227:00 amRNSPhotodisinfection effective against SARS-CoV-2
21st Feb 20227:00 amRNSGrant of Options and PDMR Dealing
7th Feb 20227:00 amRNSOndine treats first patients in Phase 2 FDA trial
20th Dec 20217:00 amRNSOndine and University of Navarra initiate clinical
15th Dec 20217:00 amRNSOndine Biomedical appoints Professor Trevor Jones
7th Dec 20217:00 amRNSOndine Biomedical appoints new Board of Directors
6th Dec 20217:00 amRNSOndine Biomedical announces AIM market listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.